GPT-Rosalind (OpenAI) vs Google Veo 3.1
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Google Veo 3.1
Google's dominant AI video generator -- native 4K at 60fps with synchronized audio, now free to every Google account via Google Vids
| Category | GPT-Rosalind (OpenAI) | Google Veo 3.1 |
|---|---|---|
| Ease of Use | 3.0 | 7.5 |
| Output Quality | 9.0 | 9.5 |
| Value | 7.0 | 6.5 |
| Features | 8.0 | 8.0 |
| Overall | 6.8 | 7.9 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | Google Veo 3.1 |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick Google Veo 3.1 if...
- ✓Easier to use (7.5 vs 3)
- ✓Has a free tier
Creators who need the highest-quality AI video available and want free or low-cost access. The April 2026 free rollout to every Google account via Google Vids makes Veo 3.1 the new default starting point for anyone trying AI video seriously. Professional production teams benefit from Ultra's unlimited generations.
Visit Google Veo 3.1Our Verdict
Google Veo 3.1 is the clear winner here with 7.9/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Google Veo 3.1 outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.